These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8252746

  • 1. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women.
    Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK.
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746
    [Abstract] [Full Text] [Related]

  • 2. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 3. Sex steroid regulation of growth hormone secretion and action.
    Ho KK, O'Sullivan AJ, Weissberger AJ, Kelly JJ.
    Horm Res; 1996 Dec; 45(1-2):67-73. PubMed ID: 8742122
    [Abstract] [Full Text] [Related]

  • 4. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women.
    Massa G, Igout A, Rombauts L, Frankenne F, Vanderschueren-Lodeweyckx M.
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):569-75. PubMed ID: 8252747
    [Abstract] [Full Text] [Related]

  • 5. Metabolic effects of oestrogens: impact of the route of administration.
    Ho KK, O'Sullivan AJ, Wolthers T, Leung KC.
    Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
    [Abstract] [Full Text] [Related]

  • 6. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ, Ho KK, Lazarus L.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [Abstract] [Full Text] [Related]

  • 7. Circulating levels of growth hormone, insulin-like growth factor-I and growth hormone binding protein in normal women of advanced reproductive age.
    Klein NA, Battaglia DE, Miller PB, Soules MR.
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):285-92. PubMed ID: 8729523
    [Abstract] [Full Text] [Related]

  • 8. Comparison of pharmacodynamic properties of various estrogen formulations.
    Mashchak CA, Lobo RA, Dozono-Takano R, Eggena P, Nakamura RM, Brenner PF, Mishell DR.
    Am J Obstet Gynecol; 1982 Nov 01; 144(5):511-8. PubMed ID: 6291391
    [Abstract] [Full Text] [Related]

  • 9. Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty.
    Kobayashi Y, Murata A, Yasuda T, Minagawa M, Wataki K, Ohnishi H, Niimi H.
    Clin Endocrinol (Oxf); 1994 Mar 01; 40(3):351-5. PubMed ID: 8187298
    [Abstract] [Full Text] [Related]

  • 10. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY, Leung KC, Baxter RC, Ho KK.
    J Clin Endocrinol Metab; 2000 May 01; 85(5):1918-22. PubMed ID: 10843175
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L, Mancini A, Izzi D, Bianchi A, Giampietro A, Fusco A, Liberale I, Rossi S, Valle D.
    Clin Endocrinol (Oxf); 2000 Jun 01; 52(6):681-5. PubMed ID: 10848871
    [Abstract] [Full Text] [Related]

  • 12. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Mouton JW, Blum WF, Mercado M, Baumann G, Drop SL.
    Clin Endocrinol (Oxf); 1993 Jul 01; 39(1):77-84. PubMed ID: 7688672
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels.
    Campagnoli C, Biglia N, Altare F, Lanza MG, Lesca L, Cantamessa C, Peris C, Fiorucci GC, Sismondi P.
    Gynecol Endocrinol; 1993 Dec 01; 7(4):251-8. PubMed ID: 8147234
    [Abstract] [Full Text] [Related]

  • 14. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.
    Clin Endocrinol (Oxf); 1999 Jun 01; 50(6):791-800. PubMed ID: 10468952
    [Abstract] [Full Text] [Related]

  • 15. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
    Ho KK, Weissberger AJ.
    J Bone Miner Res; 1992 Jul 01; 7(7):821-7. PubMed ID: 1642149
    [Abstract] [Full Text] [Related]

  • 16. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C, Vekemans M.
    Acta Endocrinol (Copenh); 1976 Sep 01; 83(1):9-14. PubMed ID: 989226
    [Abstract] [Full Text] [Related]

  • 17. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S, Collins WP, Thom MH, Studd JW.
    Br Med J; 1979 Apr 14; 1(6169):983-5. PubMed ID: 219937
    [Abstract] [Full Text] [Related]

  • 18. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V, Barash A, Shoham Z, Koistinen R, Seppala M, Hen M, Lunenfeld B, Zadik Z.
    Isr J Med Sci; 1994 Jan 14; 30(1):42-7. PubMed ID: 7511134
    [Abstract] [Full Text] [Related]

  • 19. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U, Mashchak CA, Mishell DR.
    Am J Obstet Gynecol; 1985 Apr 01; 151(7):868-77. PubMed ID: 3920910
    [Abstract] [Full Text] [Related]

  • 20. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration.
    Dick IM, Prince RL, Kelly JJ, Ho KK.
    Clin Endocrinol (Oxf); 1995 Aug 01; 43(2):219-24. PubMed ID: 7554318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.